scispace - formally typeset
Open AccessJournal ArticleDOI

Evaluation of Macrolide Resistance and Enhanced Molecular Typing of Treponema pallidum in Patients with Syphilis in Taiwan: a Prospective Multicenter Study

TLDR
It is found that type 14 f/f was the most common T. pallidum strain in this multicenter study on syphilis in Taiwan and that none of the isolates exhibited 23S rRNA mutations causing resistance to macrolides.
Abstract
Studies of macrolide resistance mutations and molecular typing using the newly proposed enhanced typing system for Treponema pallidum isolates obtained from HIV-infected patients in the Asia-Pacific region are scarce. Between September 2009 and December 2011, we conducted a survey to detect T. pallidum using a PCR assay using clinical specimens from patients with syphilis at six major designated hospitals for HIV care in Taiwan. The T. pallidum strains were genotyped by following the enhanced molecular typing methodology, which analyzed the number of 60-bp repeats in the acidic repeat protein (arp) gene, T. pallidum repeat (tpr) polymorphism, and the sequence of base pairs 131 to 215 in the tp0548 open reading frame of T. pallidum. Detection of A2058G and A2059G point mutations in the T. pallidum 23S rRNA was performed with the use of restriction fragment length polymorphism (RFLP). During the 2-year study period, 211 clinical specimens were obtained from 136 patients with syphilis. T. pallidum DNA was isolated from 105 (49.8%) of the specimens, with swab specimens obtained from chancres having the highest yield rate (63.2%), followed by plasma (49.4%), serum (35.7%), and cerebrospinal fluid or vitreous fluid (18.2%) specimens. Among the 40 fully typed specimens, 11 subtypes of T. pallidum were identified. Subtype 14f/f (18 isolates) was the most common isolates, followed by 14f/c (3), 14b/c (3), and 14k/f (3). Among the isolates examined for macrolide resistance, none had the A2058G or A2059G mutation. In conclusion, we found that type 14 f/f was the most common T. pallidum strain in this multicenter study on syphilis in Taiwan and that none of the isolates exhibited 23S rRNA mutations causing resistance to macrolides.

read more

Citations
More filters
Journal ArticleDOI

An Update on the Global Epidemiology of Syphilis

TL;DR: Continued vigilance and investment are needed to address syphilis worldwide as the epidemiology of syphilis differs in high-, and low- and middle-income countries.
Journal ArticleDOI

The Endemic Treponematoses

TL;DR: All human treponematoses share remarkable similarities in pathogenesis and clinical manifestations, consistent with the high genetic and antigenic relatedness of their etiological agents.
Journal ArticleDOI

Syphilis: Re-emergence of an old foe.

TL;DR: Genomic and proteomic studies have provided some new information concerning how this spirochete may evade host defense mechanisms to persist for long periods in the host.
Journal ArticleDOI

Syphilis: antibiotic treatment and resistance.

TL;DR: Information is presented here on the diagnosis and recommended antibiotic treatment of syphilis and the challenge of macrolide-resistant T. pallidum.

Molecular subtyping of Treponema pallidum in an arizona county with increasing syphilis morbidity : Use of specimens from ulcers and blood

TL;DR: This investigation demonstrates that multiple subtypes of T. pallidum can be found in an area with high syphilis morbidity, although 1 subtype (14f) was predominant, although 2 specimens were from epidemiologically linked patients.
References
More filters
Journal ArticleDOI

Sexually transmitted diseases treatment guidelines.

TL;DR: The new STD treatment guidelines for gonorrhea, chlamydia, bacterial vaginosis, trichomonas, vulvovaginal candidiasis, pelvic inflammatory disease, genital warts, herpes simplex virus infection, syphilis, and scabies are reviewed.
Journal ArticleDOI

Sexually transmitted disease surveillance.

C B Schofield
- 13 Mar 1982 - 

Sexually transmitted diseases treatment guidelines, 2010.

TL;DR: These guidelines for the treatment of persons who have or are at risk for sexually transmitted diseases (STDs) were updated by CDC after consultation with a group of professionals knowledgeable in the field of STDs who met in Atlanta on April 18-30, 2009.
Journal Article

Sexually transmitted diseases treatment guidelines, 2006.

TL;DR: These guidelines for the treatment of persons who have sexually transmitted diseases (STDs) were developed by CDC after consultation with a group of professionals knowledgeable in the field of STDs who met in Atlanta, Georgia, during April 19-21, 2005.
Journal Article

Global prevalence and incidence estimates of selected curable STDs.

TL;DR: Estimates of the global prevalence and incidence of these infections are limited by quantity and quality of data available from the different regions of the world and will require more well designed epidemiological studies on the prevalence and duration of infection.
Related Papers (5)